In vitro and in vivo anti-leukemic effects of cladoloside C2 are mediated by activation of Fas/ceramide synthase 6/p38 kinase/c-Jun NH2-terminal kinase/caspase-8.
about
In vitro and in vivo anti-leukemic effects of cladoloside C2 are mediated by activation of Fas/ceramide synthase 6/p38 kinase/c-Jun NH2-terminal kinase/caspase-8.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
In vitro and in vivo anti-leuk ...... NH2-terminal kinase/caspase-8.
@en
In vitro and in vivo anti-leuk ...... NH2-terminal kinase/caspase-8.
@nl
type
label
In vitro and in vivo anti-leuk ...... NH2-terminal kinase/caspase-8.
@en
In vitro and in vivo anti-leuk ...... NH2-terminal kinase/caspase-8.
@nl
prefLabel
In vitro and in vivo anti-leuk ...... NH2-terminal kinase/caspase-8.
@en
In vitro and in vivo anti-leuk ...... NH2-terminal kinase/caspase-8.
@nl
P2093
P2860
P356
P1433
P1476
In vitro and in vivo anti-leuk ...... NH2-terminal kinase/caspase-8.
@en
P2093
Alexandra S Silchenko
Eun-Hye Sim
Jin-Sook Jeong
Jin-Yeong Han
Joo-In Park
Sang-Heum Han
Seong-Hoon Yun
Sung-Hyun Kim
Tae-Rang Kim
P2860
P304
P356
10.18632/ONCOTARGET.23069
P407
P577
2017-12-08T00:00:00Z